KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Acquisitions & Divestments: 2020-2025

Historic Change in Acquisitions & Divestments for Neogenomics (NEO) over the last 5 years, with Sep 2025 value amounting to $9.0 million.

  • Neogenomics' Change in Acquisitions & Divestments rose 23.58% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year decrease of 63.64%. This contributed to the annual value of $53.9 million for FY2024, which is 51.95% down from last year.
  • Neogenomics' Change in Acquisitions & Divestments amounted to $9.0 million in Q3 2025, which was up 200.00% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Change in Acquisitions & Divestments peaked at $40.4 million during Q1 2023, and registered a low of $3.0 million during Q2 2025.
  • For the 3-year period, Neogenomics' Change in Acquisitions & Divestments averaged around $16.9 million, with its median value being $20.1 million (2024).
  • Per our database at Business Quant, Neogenomics' Change in Acquisitions & Divestments soared by 673.94% in 2021 and then tumbled by 85.29% in 2025.
  • Quarterly analysis of 5 years shows Neogenomics' Change in Acquisitions & Divestments stood at $18.2 million in 2021, then surged by 48.64% to $27.1 million in 2022, then fell by 10.52% to $24.3 million in 2023, then plummeted by 74.72% to $6.1 million in 2024, then rose by 23.58% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $3.0 million for Q2 2025, and $8.1 million during Q1 2025.